×

BRIEF-Sarepta Therapeutics jumps in premarket after eteplirsen drug trial results

NEW YORK, Oct 3 (Reuters) - Sarepta Therapeutics Inc :

* Jumps 129.2 percent to $34.35 premarket after Duchenne Muscular Dystrophy drug eteplirsen trial results

((Wall Street Newsdesk Telephone: +1 646-223-6110))